BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24358221)

  • 1. Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation.
    Chen W; Guo W; Li M; Shi D; Tian Y; Li Z; Wang J; Fu L; Xiao X; Liu QQ; Wang S; Huang W; Deng W
    PLoS One; 2013; 8(12):e82728. PubMed ID: 24358221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas.
    Chen W; Qin L; Wang S; Li M; Shi D; Tian Y; Wang J; Fu L; Li Z; Guo W; Yu W; Yuan Y; Kang T; Huang W; Deng W
    Mol Oncol; 2014 May; 8(3):704-16. PubMed ID: 24618080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CREB-binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway.
    Tang Z; Yu W; Zhang C; Zhao S; Yu Z; Xiao X; Tang R; Xuan Y; Yang W; Hao J; Xu T; Zhang Q; Huang W; Deng W; Guo W
    Mol Oncol; 2016 Feb; 10(2):317-29. PubMed ID: 26628108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
    Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
    Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage and polyadenylation specific factor 4 promotes colon cancer progression by transcriptionally activating hTERT.
    Yang Q; Fan W; Zheng Z; Lin S; Liu C; Wang R; Li W; Zuo Y; Sun Y; Hu S; Chen M; Guo P; Pan J; Tian C; Zhu T; Diao C; Hao J; Yu W; Li L; Li Y; Guo W; Deng W; Wu X
    Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1533-1543. PubMed ID: 31301362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
    Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
    Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overproduced CPSF4 Promotes Cell Proliferation and Invasion via PI3K-AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
    Zhang M; Lin H; Ge X; Xu Y
    J Oral Maxillofac Surg; 2021 May; 79(5):1177.e1-1177.e14. PubMed ID: 33535057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas.
    Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
    Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-4458 inhibits breast cancer cell growth, migration, and invasiveness by targeting CPSF4.
    Wu J; Miao J; Ding Y; Zhang Y; Huang X; Zhou X; Tang R
    Biochem Cell Biol; 2019 Dec; 97(6):722-730. PubMed ID: 30970220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CPSF4 promotes tumor-initiating phenotype by enhancing VEGF/NRP2/TAZ signaling in lung cancer.
    Song Y; Sun K; Gong L; Shi L; Qin T; Wang S; Deng W; Chen W; Zheng F; Li G
    Med Oncol; 2022 Dec; 40(1):62. PubMed ID: 36567417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling.
    Fu L; Shi K; Wang J; Chen W; Shi D; Tian Y; Guo W; Yu W; Xiao X; Kang T; Wang S; Huang W; Deng W
    Mol Cancer; 2014 Apr; 13():89. PubMed ID: 24766673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of CPSF6 in proliferation, apoptosis and tumorigenicity of lung adenocarcinoma.
    Zu Y; Wang D; Ping W; Sun W
    Aging (Albany NY); 2022 Nov; 14(22):9300-9316. PubMed ID: 36446361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
    Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
    Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma.
    Wei X; Zhang K; Qin H; Zhu J; Qin Q; Yu Y; Wang H
    BMC Cancer; 2018 May; 18(1):600. PubMed ID: 29843634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4.
    Lee K; Zheng Q; Lu Q; Xu F; Qin G; Zhai Q; Hong R; Chen M; Deng W; Wang S
    Signal Transduct Target Ther; 2021 May; 6(1):184. PubMed ID: 34006850
    [No Abstract]   [Full Text] [Related]  

  • 16. Bufalin Inhibits hTERT Expression and Colorectal Cancer Cell Growth by Targeting CPSF4.
    Zhang N; Xie Y; Tai Y; Gao Y; Guo W; Yu W; Li J; Feng X; Hao J; Gao Y; Zhao X; Liao Y; Jiang W; Liu G; Deng W; Cui X
    Cell Physiol Biochem; 2016; 40(6):1559-1569. PubMed ID: 27997899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-1 is overexpressed in CD133+ human lung adenocarcinoma cells and promotes their growth and invasiveness.
    Zhou X; Li D; Wang X; Zhang B; Zhu H; Zhao J
    Oncotarget; 2015 Feb; 6(5):3111-22. PubMed ID: 25605013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma.
    Qin J; Ning H; Zhou Y; Hu Y; Yang L; Huang R
    Biomed Pharmacother; 2018 Mar; 99():363-368. PubMed ID: 29367106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma.
    Zhan P; Xi GM; Zhang B; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu Q; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Lv TF; Song Y
    J Cell Mol Med; 2017 Apr; 21(4):665-676. PubMed ID: 27862966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Expression of Krüppel-like Factor 7 Indicates Unfavorable Clinical Outcomes in Patients with Lung Adenocarcinoma.
    Niu R; Tang Y; Xi Y; Jiang D
    J Surg Res; 2020 Jun; 250():216-223. PubMed ID: 32092599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.